Kei Miyoshi

508 total citations
13 papers, 401 citations indexed

About

Kei Miyoshi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Kei Miyoshi has authored 13 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 3 papers in Surgery. Recurrent topics in Kei Miyoshi's work include Lung Cancer Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer Cells and Metastasis (2 papers). Kei Miyoshi is often cited by papers focused on Lung Cancer Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer Cells and Metastasis (2 papers). Kei Miyoshi collaborates with scholars based in Japan. Kei Miyoshi's co-authors include Noriaki Tsubota, Takeshi Mimura, Tsuyoshi Yuki, Toshihiko Sakamoto, Morihito Okada, Kazuhiro Mizumoto, Kenoki Ohuchida, Masao Tanaka, Morihito Okada and Takuya Egami and has published in prestigious journals such as CHEST Journal, Journal of Thoracic and Cardiovascular Surgery and The Annals of Thoracic Surgery.

In The Last Decade

Kei Miyoshi

12 papers receiving 395 citations

Peers

Kei Miyoshi
Yangki Seok South Korea
Chang Hun Lee South Korea
Mariela Blum‐Murphy United States
Hester C. van Wyk United Kingdom
Yangki Seok South Korea
Kei Miyoshi
Citations per year, relative to Kei Miyoshi Kei Miyoshi (= 1×) peers Yangki Seok

Countries citing papers authored by Kei Miyoshi

Since Specialization
Citations

This map shows the geographic impact of Kei Miyoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kei Miyoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kei Miyoshi more than expected).

Fields of papers citing papers by Kei Miyoshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kei Miyoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kei Miyoshi. The network helps show where Kei Miyoshi may publish in the future.

Co-authorship network of co-authors of Kei Miyoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Kei Miyoshi. A scholar is included among the top collaborators of Kei Miyoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kei Miyoshi. Kei Miyoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ozono, Keigo, Hideya Onishi, Katsuya Nakamura, et al.. (2022). Tropomyosin-related Kinase B Is Potentially a Biomarker of Prognosis and Therapeutic Target for Malignant Thymic Epithelial Tumors. Anticancer Research. 42(8). 3779–3787. 2 indexed citations
2.
Onishi, Hideya, Akiko Fujimura, Akira Imaizumi, et al.. (2021). PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor. Translational Oncology. 14(9). 101152–101152. 9 indexed citations
4.
Nakayama, Hiromichi, Kenoki Ohuchida, Yohei Ando, et al.. (2019). S100P regulates the collective invasion of pancreatic cancer cells into the lymphatic endothelial monolayer. International Journal of Oncology. 55(1). 211–222. 19 indexed citations
5.
Uchiyama, Akihiko, Kei Miyoshi, & Katsuya Nakamura. (2011). VIO soft-coagulation system for major pulmonary resections: results in 68 patients with primary lung cancer. General Thoracic and Cardiovascular Surgery. 59(3). 175–178. 18 indexed citations
6.
Miyoshi, Kei, et al.. (2010). Surgical treatment of clinical N1 non-small cell lung cancer: Ongoing controversy over diagnosis and prognosis. Surgery Today. 40(5). 428–432. 12 indexed citations
7.
Miyoshi, Kei, Norihiro Sato, Kenoki Ohuchida, Kazuhiro Mizumoto, & Masao Tanaka. (2010). SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.. PubMed. 30(3). 867–71. 31 indexed citations
8.
Egami, Takuya, Kenoki Ohuchida, Kei Miyoshi, et al.. (2009). Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer. Cancer Science. 100(4). 722–729. 13 indexed citations
9.
Fujita, Hayato, Kenoki Ohuchida, Kazuhiro Mizumoto, et al.. (2009). Tumor–stromal interactions with direct cell contacts enhance proliferation of human pancreatic carcinoma cells. Cancer Science. 100(12). 2309–2317. 62 indexed citations
10.
Okada, Morihito, Toshihiko Sakamoto, Tsuyoshi Yuki, et al.. (2006). Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer. The Annals of Thoracic Surgery. 81(3). 1028–1032. 113 indexed citations
11.
Yamanouchi, Yoshio, et al.. (2006). Orally administered levofloxacin as prophylaxis against pacemaker infection.. PubMed. 11(1). 21–4. 3 indexed citations
12.
Okada, Morihito, Toshihiko Sakamoto, Tsuyoshi Yuki, et al.. (2005). Border between N1 and N2 stations in lung carcinoma: Lessons from lymph node metastatic patterns of lower lobe tumors. Journal of Thoracic and Cardiovascular Surgery. 129(4). 825–830. 35 indexed citations
13.
Okada, Morihito, Toshihiko Sakamoto, Tsuyoshi Yuki, et al.. (2005). Hybrid Surgical Approach of Video-Assisted Minithoracotomy for Lung Cancer. CHEST Journal. 128(4). 2696–2701. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026